Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow

Scott Mcdonald, Sharon Hutchinson, S.O. Cameron, Hamish Innes, Allan McLeod, David J. Goldberg

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Unsafe injecting practices put injecting drug users (IDUs) at repeat exposure to infection with the hepatitis C virus (HCV). It has not yet been determined if spontaneously clearing one's primary infection influences the risk of reinfection; our aim was to estimate the relative risk of reinfection in IDUs who have cleared the virus.
We conducted a retrospective study using a large database of HCV test results covering Greater Glasgow Health Board during 1993–2007 to calculate rates of infection and reinfection in current/former IDUs. The relative risk of (re)infection in previously infected compared with never-infected IDUs was estimated using Poisson regression, adjusting for age at study entry, sex, and calendar period of test.
Although the rate of reinfection in IDUs who were HCV antibody-positive, RNA-negative at baseline was lower (7/100 person-years, 95% CI: 5–9) than the rate of acute infection in IDUs who were HCV antibody-negative at baseline (10/100 person-years, 95% CI: 9–12), the risk of reinfection was not significantly different than the risk of initial infection (adjusted rate ratio = 0.78, 95% CI: 0.57–1.08).
We found only weak evidence for a reduced risk of HCV reinfection in IDUs who had cleared their previous infection. Further research among those who have cleared infection through antiviral therapy is needed to help inform decisions regarding treatment of IDUs.




LanguageEnglish
Pages353-357
Number of pages5
JournalInternational Journal of Drug Policy
Volume23
Issue number5
Early online date13 Mar 2012
DOIs
Publication statusPublished - Sep 2012

Fingerprint

Hepatitis C
Drug Users
Infection
Hepacivirus
Hepatitis C Antibodies
Antiviral Agents
Retrospective Studies
Databases
RNA
Viruses
Health
Therapeutics
Research

Keywords

  • mathematical analysis
  • hepatitis C
  • infection
  • risk of reinfection
  • injecting drug users
  • glasgow
  • examination
  • risk
  • hepatitis C virus
  • intravenous substance abuse
  • incidence
  • epidemiology

Cite this

Mcdonald, Scott ; Hutchinson, Sharon ; Cameron, S.O. ; Innes, Hamish ; McLeod, Allan ; Goldberg, David J. / Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. In: International Journal of Drug Policy. 2012 ; Vol. 23, No. 5. pp. 353-357.
@article{7223084f3f8344c2b9dd185059ee9486,
title = "Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow",
abstract = "Unsafe injecting practices put injecting drug users (IDUs) at repeat exposure to infection with the hepatitis C virus (HCV). It has not yet been determined if spontaneously clearing one's primary infection influences the risk of reinfection; our aim was to estimate the relative risk of reinfection in IDUs who have cleared the virus. We conducted a retrospective study using a large database of HCV test results covering Greater Glasgow Health Board during 1993–2007 to calculate rates of infection and reinfection in current/former IDUs. The relative risk of (re)infection in previously infected compared with never-infected IDUs was estimated using Poisson regression, adjusting for age at study entry, sex, and calendar period of test. Although the rate of reinfection in IDUs who were HCV antibody-positive, RNA-negative at baseline was lower (7/100 person-years, 95{\%} CI: 5–9) than the rate of acute infection in IDUs who were HCV antibody-negative at baseline (10/100 person-years, 95{\%} CI: 9–12), the risk of reinfection was not significantly different than the risk of initial infection (adjusted rate ratio = 0.78, 95{\%} CI: 0.57–1.08). We found only weak evidence for a reduced risk of HCV reinfection in IDUs who had cleared their previous infection. Further research among those who have cleared infection through antiviral therapy is needed to help inform decisions regarding treatment of IDUs.",
keywords = "mathematical analysis, hepatitis C, infection, risk of reinfection, injecting drug users, glasgow, examination, risk, hepatitis C virus, intravenous substance abuse, incidence, epidemiology",
author = "Scott Mcdonald and Sharon Hutchinson and S.O. Cameron and Hamish Innes and Allan McLeod and Goldberg, {David J.}",
year = "2012",
month = "9",
doi = "10.1016/j.drugpo.2012.02.003",
language = "English",
volume = "23",
pages = "353--357",
journal = "International Journal of Drug Policy",
issn = "0955-3959",
number = "5",

}

Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow. / Mcdonald, Scott; Hutchinson, Sharon; Cameron, S.O.; Innes, Hamish; McLeod, Allan; Goldberg, David J.

In: International Journal of Drug Policy, Vol. 23, No. 5, 09.2012, p. 353-357.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow

AU - Mcdonald, Scott

AU - Hutchinson, Sharon

AU - Cameron, S.O.

AU - Innes, Hamish

AU - McLeod, Allan

AU - Goldberg, David J.

PY - 2012/9

Y1 - 2012/9

N2 - Unsafe injecting practices put injecting drug users (IDUs) at repeat exposure to infection with the hepatitis C virus (HCV). It has not yet been determined if spontaneously clearing one's primary infection influences the risk of reinfection; our aim was to estimate the relative risk of reinfection in IDUs who have cleared the virus. We conducted a retrospective study using a large database of HCV test results covering Greater Glasgow Health Board during 1993–2007 to calculate rates of infection and reinfection in current/former IDUs. The relative risk of (re)infection in previously infected compared with never-infected IDUs was estimated using Poisson regression, adjusting for age at study entry, sex, and calendar period of test. Although the rate of reinfection in IDUs who were HCV antibody-positive, RNA-negative at baseline was lower (7/100 person-years, 95% CI: 5–9) than the rate of acute infection in IDUs who were HCV antibody-negative at baseline (10/100 person-years, 95% CI: 9–12), the risk of reinfection was not significantly different than the risk of initial infection (adjusted rate ratio = 0.78, 95% CI: 0.57–1.08). We found only weak evidence for a reduced risk of HCV reinfection in IDUs who had cleared their previous infection. Further research among those who have cleared infection through antiviral therapy is needed to help inform decisions regarding treatment of IDUs.

AB - Unsafe injecting practices put injecting drug users (IDUs) at repeat exposure to infection with the hepatitis C virus (HCV). It has not yet been determined if spontaneously clearing one's primary infection influences the risk of reinfection; our aim was to estimate the relative risk of reinfection in IDUs who have cleared the virus. We conducted a retrospective study using a large database of HCV test results covering Greater Glasgow Health Board during 1993–2007 to calculate rates of infection and reinfection in current/former IDUs. The relative risk of (re)infection in previously infected compared with never-infected IDUs was estimated using Poisson regression, adjusting for age at study entry, sex, and calendar period of test. Although the rate of reinfection in IDUs who were HCV antibody-positive, RNA-negative at baseline was lower (7/100 person-years, 95% CI: 5–9) than the rate of acute infection in IDUs who were HCV antibody-negative at baseline (10/100 person-years, 95% CI: 9–12), the risk of reinfection was not significantly different than the risk of initial infection (adjusted rate ratio = 0.78, 95% CI: 0.57–1.08). We found only weak evidence for a reduced risk of HCV reinfection in IDUs who had cleared their previous infection. Further research among those who have cleared infection through antiviral therapy is needed to help inform decisions regarding treatment of IDUs.

KW - mathematical analysis

KW - hepatitis C

KW - infection

KW - risk of reinfection

KW - injecting drug users

KW - glasgow

KW - examination

KW - risk

KW - hepatitis C virus

KW - intravenous substance abuse

KW - incidence

KW - epidemiology

UR - http://www.scopus.com/inward/record.url?scp=84866175363&partnerID=8YFLogxK

U2 - 10.1016/j.drugpo.2012.02.003

DO - 10.1016/j.drugpo.2012.02.003

M3 - Article

VL - 23

SP - 353

EP - 357

JO - International Journal of Drug Policy

T2 - International Journal of Drug Policy

JF - International Journal of Drug Policy

SN - 0955-3959

IS - 5

ER -